We have recently demonstrated that the intracellular increase of FHC amounts leads to enhancement of p53 protein expression in H460 non-small-cell lung cancer (NSCLC) cells and that this is accompanied by a significant reduction of the cell proliferation rate24. This evidence concerns the gene FTH1 and non-small cell lung carcinoma.